These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2670325)
21. [Hyperlipidemias: occurrence, significance, therapy]. Knüchel F Med Welt; 1967 Aug; 32():1848-60. PubMed ID: 5589916 [No Abstract] [Full Text] [Related]
22. [Fatty acid composition of the steroids of the main classes of beta-lipoproteins isolated by ultracentrifugation in normal and hyperglyceridemic subjects with or without associated atheroma]. Jaillard J; Sézille G; Scherpereel P; Fruchart JC; Biserte G Pathol Biol (Paris); 1972 Jan; 20(1):51-6. PubMed ID: 4552030 [No Abstract] [Full Text] [Related]
23. [Lipoprotein profile estimated by nephelometry in peripheral arterial disease (author's transl)]. Fellin R; Settembrini PG; Bagnariol G; Briani G; Marchetto S; De Riu GP; Baggio G; Crepaldi G G Ital Cardiol; 1974; 4(5):613-21. PubMed ID: 4435329 [No Abstract] [Full Text] [Related]
25. [Dyslipidemia, atherosclerosis and heart disease. Epidemiology and prevention]. Rabaneda Vallecillos R Rev Enferm; 1990 Dec; 13(148):68-73. PubMed ID: 2277915 [No Abstract] [Full Text] [Related]
26. [Effect of sodium d-thyroxine on the hiperlipedemia, hypercholesteremia, triglycerides and serum lipoproteins in patients with arteriosclerosis]. Mazzei ES; Mazzei CM; Gotelli C Prensa Med Argent; 1967 Mar; 54(5):199-203. PubMed ID: 5605172 [No Abstract] [Full Text] [Related]
27. [Current trends in the therapy of arteriosclerotic disease]. Toscano S G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524 [No Abstract] [Full Text] [Related]
28. [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin]. Kurmukov AG; Aĭzikov MI; Rasulova SA; Makhmudov OKh Farmakol Toksikol; 1986; 49(6):54-7. PubMed ID: 3817147 [TBL] [Abstract][Full Text] [Related]
29. Protein-lipoprotein interactions in man: a reexamination. Kayden HJ Ann N Y Acad Sci; 1976; 275():145-52. PubMed ID: 64127 [No Abstract] [Full Text] [Related]
30. Effect of long-term treatment with sulfatide on hyperlipidemia and progression of atherosclerosis in WHHL rabbits. Taketomi T; Hara A; Uemura K; Kyogashima N Jpn J Exp Med; 1989 Dec; 59(6):221-31. PubMed ID: 2622064 [TBL] [Abstract][Full Text] [Related]
31. [Effect of seasonal factors on blood lipid levels and some blood coagulation indices in patients with arteriosclerosis and essential hyperlipidemia]. Krivoruchenko IV Kardiologiia; 1970 Oct; 10(10):35-41. PubMed ID: 5504114 [No Abstract] [Full Text] [Related]
32. [Gemfibrozil in the treatment of lipid metabolism disorders]. Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321 [TBL] [Abstract][Full Text] [Related]
34. [The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis]. Forti N; Dereviacki BE; Giannini SD Arq Bras Cardiol; 1988 Jul; 51(1):49-53. PubMed ID: 3073736 [No Abstract] [Full Text] [Related]
35. [The role of nicotinic acid in the treatment of atherosclerosis and atherogenic dyslipidemia]. Aronov DM Klin Med (Mosk); 1996; 74(9):48-52. PubMed ID: 9121091 [No Abstract] [Full Text] [Related]
36. [Lipids and atherosclerosis]. González Santos P; De la Higuera Rojas J Rev Clin Esp; 1974 Mar; 132(5):387-98. PubMed ID: 4208680 [No Abstract] [Full Text] [Related]
37. [Plasmatic coagulation factors in hyperlipoproteinemias]. Zöller H; Fromme K; Gross W MMW Munch Med Wochenschr; 1974 Feb; 116(5):201-4. PubMed ID: 4360448 [No Abstract] [Full Text] [Related]